Minerva Neurosciences, Inc. Increase (Decrease) in Other Noncurrent Assets
Minerva Neurosciences, Inc. (NERV) reported Increase (Decrease) in Other Noncurrent Assets of -$14.81 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2023-03-08
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2021-12-31 was $0.00.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent assets for fiscal 2021 was -$14.81K.
- Minerva Neurosciences, Inc. increase (decrease) in other noncurrent assets for fiscal 2017 was $14.81K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$14.81K 10-K · filed 2023-03-08 | |
| 2021-09-30 | -$14.81K 10-Q · filed 2022-11-09 | ||
| 2017-12-31 | $14.81K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |